Compounds > 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
Page last updated: 2024-09-03

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Angiogenesis, Pathologic

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, HL; Qi, XR; Zhao, W1

Other Studies

1 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Angiogenesis, Pathologic

ArticleYear
[Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:9

    Topics: Animals; Aorta; Cell Line, Tumor; Cholesterol; Doxorubicin; Drug Carriers; Drug Delivery Systems; Endothelial Cells; Female; Liposomes; Liver Neoplasms, Experimental; Male; Mice; Neovascularization, Pathologic; Particle Size; Rats; Rats, Sprague-Dawley

2007